Fabric Genomics
Founded Year
2009Stage
Loan | AliveTotal Raised
$30.48MLast Raised
$680K | 3 yrs agoAbout Fabric Genomics
Fabric Genomics, formerly Omicia, is a computational genomics company offering end-to-end genomic data analysis, annotation, curation, classification and reporting solutions to clinical labs, hospital labs, country sequencing programs and life science companies. Fabric Genomics' analytic capabilities begin with raw data analysis and include the delivery of rapid, comprehensive insights for high throughout panels, exomes, and whole genomes. The company can process any NGS file input (e.g. FASTQ, BAM or VCF) providing alignment, variant calling, annotation, guideline-driven variant classification, variant interpretation and clinical reporting for both hereditary disease and oncology. Fabric Genomics was founded by scientists and industry pioneers in bioinformatics, large-scale genomics and molecular diagnostics, and is headquartered in Oakland, California with satellite offices in London, Seattle, Salt Lake City and Boston. By accelerating access to insights related to the cause of genetic diseases, Fabric Genomics is leading the way in precision healthcare.
Missing: Fabric Genomics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
ESPs containing Fabric Genomics
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
Startups in this market use genetic screening services to identify individuals with hereditary risks for disease, including cancer and heart conditions. As the market for direct-to-consumer genomics wanes — partially due to increased FDA regulation — companies in this space have pivoted to partner with healthcare providers and integrate genomics data into clinical care.
Fabric Genomics named as Challenger among 13 other companies, including Color, Congenica, and PierianDx.
Missing: Fabric Genomics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Fabric Genomics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Fabric Genomics is included in 6 Expert Collections, including Cancer.
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Omics
1,267 items
Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data
Digital Hospital
198 items
Startups recreating how healthcare is delivered
Digital Health
12,523 items
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Biopharma Tech
260 items
Precision Medicine Tech Market Map
160 items
This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.
Fabric Genomics Patents
Fabric Genomics has filed 5 patents.
The 3 most popular patent topics include:
- Genetics
- Molecular biology
- Bioinformatics
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
3/15/2018 | Molecular biology, Genomics, Genetics, Bioinformatics, Biological databases | Application |
Application Date | 3/15/2018 |
|---|---|
Grant Date | |
Title | |
Related Topics | Molecular biology, Genomics, Genetics, Bioinformatics, Biological databases |
Status | Application |
Latest Fabric Genomics News
Feb 7, 2023
| Syapse, Inc., 2bPrecise LLC, Fabric Genomics News Provided By Share This Article Precision Medicine Software Market Analysis Precision medicine software is an emerging approach for the prevention and treatment of diseases such as cancer, rare illness, and infectious diseases. BURLINGAME, CALIFORNIA, UNITED STATES, February 7, 2023 / EINPresswire.com / -- Edition : 2023 The latest published research the “ Precision Medicine Software Market ” report provides the overall growth and business outlook of the global industry. The assessment presented in the CMI research report gives thorough data and analysis of major important facets such as growth drivers, challenges, restraints, present and historical trends, and growth opportunities in the market. The report research covers valuable information on the business with insights, applications, and the industrial chain structure. And this adding report provides market sizing and forecast across the globe. It helps organization leaders make better decisions when currency exchange data is readily available. Additionally, it contains knowledge of the worldwide market competition landscape, development status, segments, and sub-segments of an industry that influence the growth scenario of the present market. To remain ‘ahead’ of your competitors, request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2683 ** Note – This report sample includes: ▪️ Scope For 2023 ▪️ Table of Contents (Scope covered as a part of the study) ▪️ Top players in the market ▪️ Research framework (structure of the report) ▪️ Research methodology adopted by Coherent Market Insights Market Competitor Analysis: The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Precision Medicine Software market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information for the last 3 years, and key development in the past five years. Further, the report presents profiles of competitors in the market, Top Key Players include: ✤ Syapse Inc. Benefits of Precision Medicine Software Market Reports: ✣ Customer Satisfaction: Our team of experts assists you with all your research needs and optimizes your reports. ✣ Analyst Support: Before or after purchasing the report, ask a professional analyst to address your questions. ✣ Assured Quality: Focuses on the accuracy and quality of reports. ✣ Incomparable Skills: Analysts provide in-depth insights into reports. Ask Here for More Customization Study @ https://www.coherentmarketinsights.com/insight/request-customization/2683 Global and Regional Market Analysis: The Precision Medicine Software Market report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This report mentions the market share and growth rate of each region, country, and sub-region during the estimated period. Additional information, the Precision Medicine Software market study covers noteworthy research data and proofs to be a handy resource record for managers, analysts, industry experts, and other key people to have a ready-to-access and self-analyzed study to help understand market patterns. ☑️ North America (United States, Canada, and Mexico) ☑️ Europe (Germany, France, UK, Russia, and Italy) ☑️ Asia-Pacific (China, Japan, Korea, India, and Southeast Asia) ☑️ South America (Brazil, Argentina, Colombia, etc.) ☑️ The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa) Key Reasons to Purchase Precision Medicine Software Market Report: ►The report analysis by geography highlights the consumption of the product/service within the region and also as indicating the factors that are affecting the market within each region ►The report provides opportunities and threats faced by the vendors in the Precision Medicine Software Market. The report indicates the region and segment that’s expected to witness the fastest growth ►The competitive landscape includes the market ranking of the main players, along with new product launches, partnerships, business expansions ►The report provides extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the main market players ►The report gives the present as well as the future market outlook of the industry regarding recent developments, growth opportunities, drivers, challenges, and restraints of both emerging also as developed regions For in-depth competitive analysis, buy now and Get Up to 45% Discount @ https://www.coherentmarketinsights.com/promo/buynow/2683 Key Questions Answered in This Precision Medicine Software Market Report : ✓ How much revenue will the Precision Medicine Software market generate by the end of the forecast period? ✓ Which market segment is expected to have the maximum market share? ✓ What are the influencing factors and their impact on the Precision Medicine Software market? ✓ Which regions are currently contributing the maximum share of the overall Precision Medicine Software market? ✓ What are the main advances in the Precision Medicine Software market? Mr. Shah +1 206-701-6702
Fabric Genomics Frequently Asked Questions (FAQ)
When was Fabric Genomics founded?
Fabric Genomics was founded in 2009.
Where is Fabric Genomics's headquarters?
Fabric Genomics's headquarters is located at 1611 Telegraph Avenue, Oakland.
What is Fabric Genomics's latest funding round?
Fabric Genomics's latest funding round is Loan.
How much did Fabric Genomics raise?
Fabric Genomics raised a total of $30.48M.
Who are the investors of Fabric Genomics?
Investors of Fabric Genomics include Paycheck Protection Program, Artis Ventures, Buchanan Investments, Acadia Woods Partners, The University of Pittsburgh Medical Center and 8 more.
Who are Fabric Genomics's competitors?
Competitors of Fabric Genomics include Q-State Biosciences and 1 more.
Compare Fabric Genomics to Competitors
Congenica provides clinical genome analysis technology. Congenica has developed the Sapientia technology platform to analyze genome-scale DNA data, producing comprehensive diagnostic reports that facilitate clinical decision-making and inform R&D.
Gene42 is a medical technology and clinical software company that develops clinical software tools for collecting and analyzing phenotypic information for patients with genetic disorders and cancers. Their solution, PhenoTips, allows for efficient recording of patient data in a standardized format, which facilitates automated searches of annotated genes and disease databases (differential diagnosis), enables effortless querying and sharing of anonymized patient data by users and provides a user-friendly interface with advanced features that reduces clinician's workload and seamlessly integrates into clinical work flow. Gene42 provides support contracts and custom development for PhenoTips software. Data organization when it comes to patient care is critical, especially in rare diseases when certain symptoms or features of a disease might not be seen on a regular basis. In the age of "big data" and electronic health records, Gene42 is striving to make personalized medicine more effective for patients and their doctors.
Navican provides a personalized approach to testing, diagnosing, and treating cancer. The company's unique process analyzes the genetic makeup of a patient's cancer and employs a team of skilled molecular tumor specialists to review each test and determine how to most effectively treat that cancer case.
Tempus builds a library of molecular and clinical data as well as a corresponding operating system for data accessibility and use. The company enables physicians to deliver personalized cancer care for patients through its interactive analytical and machine-learning platform. It provides genomic sequencing services and molecular and therapeutic data analysis to empower physicians to make real-time, data-driven decisions. It serves clients in the healthcare sector. The company was founded in 2015 and is based in Chicago, Illinois.
Emedgene provides data-driven AI solutions for genomic diagnostics and discovery at scale. The company works with top healthcare and life sciences organizations to enable precision medicine programs, power high throughput diagnostics, and accelerate the pace of research.
Q-State Biosciences is a precision medicine company creating new genetically targeted medicines for people living with nervous system disorders. The company's proprietary ResQueTM Platform incorporates a suite of technologies to map each patient’s unique genome to a genetic therapy that targets the root cause of disease.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.